Cargando…
Management of Pemphigus in COVID-19 Pandemic Era; a Review Article
The novel coronavirus is rapidly spreading around the world. Since the public announcement of the COVID-19 outbreak, several concerns have been raised by dermatologists as well as pemphigus patients who take immunosuppressive drugs. In this paper, we review the literature about the common treatment...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shahid Beheshti University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212074/ https://www.ncbi.nlm.nih.gov/pubmed/32440662 |
_version_ | 1783531555010904064 |
---|---|
author | Abdollahimajd, Fahimeh Shahidi-Dadras, Mohammad M Robati, Reza Dadkhahfar, Sahar |
author_facet | Abdollahimajd, Fahimeh Shahidi-Dadras, Mohammad M Robati, Reza Dadkhahfar, Sahar |
author_sort | Abdollahimajd, Fahimeh |
collection | PubMed |
description | The novel coronavirus is rapidly spreading around the world. Since the public announcement of the COVID-19 outbreak, several concerns have been raised by dermatologists as well as pemphigus patients who take immunosuppressive drugs. In this paper, we review the literature about the common treatment of pemphigus with a focus on the lessons from similar epidemics to find a proper suggestion to manage pemphigus in the COVID-19 pandemic era. The effect of many of the drugs used for treatment of Pemphigus vulgaris (PV) on COVID-19 is not clear. We also do not have data on the impact of this autoimmune disease, which may involve the mucous membranes, on the acquisition or course of COVID-19. We are currently in the midst of a pandemic and evaluating the effect of COVID-19 on the population of susceptible patients suffering from auto-immune diseases like pemphigus is essential. The evidence on best ways to manage patients with underlying conditions, such as pemphigus, during the outbreak of COVID-19 is evolving and the data is updated every day. |
format | Online Article Text |
id | pubmed-7212074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Shahid Beheshti University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-72120742020-05-21 Management of Pemphigus in COVID-19 Pandemic Era; a Review Article Abdollahimajd, Fahimeh Shahidi-Dadras, Mohammad M Robati, Reza Dadkhahfar, Sahar Arch Acad Emerg Med Review Article The novel coronavirus is rapidly spreading around the world. Since the public announcement of the COVID-19 outbreak, several concerns have been raised by dermatologists as well as pemphigus patients who take immunosuppressive drugs. In this paper, we review the literature about the common treatment of pemphigus with a focus on the lessons from similar epidemics to find a proper suggestion to manage pemphigus in the COVID-19 pandemic era. The effect of many of the drugs used for treatment of Pemphigus vulgaris (PV) on COVID-19 is not clear. We also do not have data on the impact of this autoimmune disease, which may involve the mucous membranes, on the acquisition or course of COVID-19. We are currently in the midst of a pandemic and evaluating the effect of COVID-19 on the population of susceptible patients suffering from auto-immune diseases like pemphigus is essential. The evidence on best ways to manage patients with underlying conditions, such as pemphigus, during the outbreak of COVID-19 is evolving and the data is updated every day. Shahid Beheshti University of Medical Sciences 2020-04-18 /pmc/articles/PMC7212074/ /pubmed/32440662 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Abdollahimajd, Fahimeh Shahidi-Dadras, Mohammad M Robati, Reza Dadkhahfar, Sahar Management of Pemphigus in COVID-19 Pandemic Era; a Review Article |
title | Management of Pemphigus in COVID-19 Pandemic Era; a Review Article |
title_full | Management of Pemphigus in COVID-19 Pandemic Era; a Review Article |
title_fullStr | Management of Pemphigus in COVID-19 Pandemic Era; a Review Article |
title_full_unstemmed | Management of Pemphigus in COVID-19 Pandemic Era; a Review Article |
title_short | Management of Pemphigus in COVID-19 Pandemic Era; a Review Article |
title_sort | management of pemphigus in covid-19 pandemic era; a review article |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212074/ https://www.ncbi.nlm.nih.gov/pubmed/32440662 |
work_keys_str_mv | AT abdollahimajdfahimeh managementofpemphigusincovid19pandemiceraareviewarticle AT shahididadrasmohammad managementofpemphigusincovid19pandemiceraareviewarticle AT mrobatireza managementofpemphigusincovid19pandemiceraareviewarticle AT dadkhahfarsahar managementofpemphigusincovid19pandemiceraareviewarticle |